Refine by
Diabetes And Obesity Articles & Analysis
23 articles found
Moreover, lipidomic shifts can also reveal insights into metabolic conditions such as obesity, diabetes, and neurodegenerative diseases. For instance, certain lipid species found in exosomes may indicate disrupted signaling pathways or abnormal cellular function, providing opportunities for therapeutic intervention. ...
Disturbances in metabolic pathways can lead to many common human diseases such as cancer, diabetes, obesity, hypoglycemia, hypolipidemia, phenylketonuria, neurodegeneration, etc. ...
Dysbiosis of the intestinal flora is associated with a variety of human metabolic diseases, such as obesity, diabetes mellitus, and nonalcoholic fatty liver disease. Regulation of lipoprotein metabolism by intestinal flora The intestine is not only a site of lipid digestion and absorption, but also a place where a large number of microorganisms reside. ...
Dysbiosis, an imbalance in gut microbial communities, has been linked to altered bile acid metabolism and, consequently, to diseases like non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. A landmark study conducted in collaboration with Creative Proteomics investigated the bidirectional relationship between bile acids and the gut microbiota in NAFLD. ...
Diabetes, specifically Type 1 and Type 2 Diabetes Mellitus, remains one of the most commonly encountered metabolic diseases worldwide. ...
More than 95 percent of people with diabetes have type 2 diabetes (formerly known as non-insulin-dependent diabetes or adult-onset diabetes), which is characterized by the body's abnormal use of insulin that affects the body's use of glucose for energy, mainly due to obesity, physical inactivity and genetics. 2. ...
In addition, our previous study also found that tetrahydrocurcumin has a good therapeutic effect on metabolic syndrome, obesity type 2 diabetes, hypertension, insulin resistance syndrome and other related diseases, and has a wide range of application prospects. 1.Hypoglycemic Effect Murugan P et al. induced type 2 diabetes mouse model with ...
This type of inflammation specifically results from noncardiac metabolic risk factors, including obesity, diabetes, anemia, hypertension, chronic obstructive pulmonary disease (COPD), auto-immune diseases, and renal insufficiency. [4] Other Key Differences Between HFpEF and HFrEF: Risk Factors, Diagnosis, and Treatment Risk factors Molecular and cellular ...
HFpEF patients are likely to have a high prevalence of cardiovascular and non-cardiovascular comorbidities, such as obesity, metabolic syndrome, diabetes mellitus type 2, salt-sensitive hypertension, atrial fibrillation (AF), chronic obstructive pulmonary disease, anaemia, and renal dysfunction.[6.7,8] As life expectancy and comorbidity rates rise, the ...
Friedlander's lab has also shown that Moreover, PiT1-deficient mice were protected against high-fat-diet-induced obesity and ...
Physical signs of heart failure (HF) (such as elevated jugular venous pressure, pulmonary rales, and lower extremity edema) may or may not be present. [9] A history of atrial fibrillation (AF), obesity, and diabetes all increase the likelihood of HFpEF. [10] (Table 1). ...
BioLingus will position these products in the “epidemic” markets of obesity and type II diabetes : More than 400 MM people suffer from diabetes today. ...
Obesity is a major risk factor for diabetes and leads to insulin resistance that often precedes diabetes. ...
It is no secret that glucose, a form of sugar, is the main source of energy for every cell in our bodies, including our brain cells. Because the brain is packed with neurons, it uses more energy than any other organ in the body. Our brains reward us for consuming sugar. Whether you are eating a delicious meal, sharing a kiss with someone you love, or enjoying a sugary treat, the mesolimbic ...
The increasing incidence of peripheral artery disease (PAD) is occurring globally as populations age and rates of diabetes, obesity, and renal disease increase.1-3 Although most of these patients have no symptoms, when the disease progresses to its most advanced form, chronic limb-threatening ischemia (CLTI), there is a significant risk for limb loss. ...
NAFL is more common in people who have certain conditions such as obesity and type 2 diabetes. Researchers have found NAFL in 40 to 80 percent of people who have type 2 diabetes and in 30 to 90 percent of people who are obese 01 Additionally, it is estimated that 1 in 4 people around the world have some sort of NAFL while in the ...
ByAlgatech
Glucose clamping has become a standard, widely used technique in researching diabetes treatment as well as obesity and fatty liver studies. We've taken a look at the types and applications of clamp study and their impact on the field. ...
In the long run, a lack of quality sleep has been associated with obesity, diabetes, cardiovascular disease, and even early mortality. The most common sleep disorders are insomnia, sleep apnea, snoring, restlessness, sleepwalking and narcolepsy. ...
Considering the parallel rise in chronic diseases (like diabetes, obesity and heart disease) with trends in fossil fuel use around the globe, our greatest challenge today (and opportunity) lies at the nexus of health and energy. ...
ByEnsia
Individual study weights were created using the inverse of the variance using the method proposed by DerSimonian and Laird.10 Stratified analyses were also performed on variables selected a priori to potentially affect the outcomes of interest, such as gender, age, race, diabetes status, obesity, cardiovascular disease status, access location, time on dialysis, ...